ClinConnect ClinConnect Logo
Search / Trial NCT05876143

Ambispective Multicentric Study Evaluating UKA With U-Knee/Uni-Kroma Implants

Launched by SOCIETE DETUDE, DE RECHERCHE ET DE FABRICATION · May 24, 2023

Trial Information

Current as of August 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a specific type of knee implant called the U-Knee/Uni-Kroma, which is used for a surgery known as unicompartmental knee arthroplasty. This surgery is typically done to relieve pain and improve movement in patients with arthritis or damage in just one part of the knee. The main goal of the study is to gather information about how well these implants work in the short and medium term after surgery.

To be eligible for this study, participants need to be between the ages of 65 and 74 and must have received a U-Knee/Uni-Kroma implant. They should also be part of a social security program. However, people who have another knee implant that needs to be replaced, or who can't follow the study's instructions or complete questionnaires, won’t be able to participate. Those who join the trial can expect to provide feedback on their recovery and the performance of the implant, helping researchers understand how this device can improve knee function for others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - All patients using a U-Knee / Uni-Kroma unicompartmental knee prosthesis and benefiting from the social security affiliation scheme.
  • Exclusion Criteria:
  • Patients who objected to participating in the study and the processing of their data
  • Patients unable to understand the surgeon's instructions to complete their questionnaires or perform postoperative follow-up
  • Patients who already have a unicompartmental prosthesis on the knee in question that need to be revised.

About Societe Detude, De Recherche Et De Fabrication

Société d'Étude, de Recherche et de Fabrication (SERF) is a leading clinical trial sponsor dedicated to advancing medical innovation through rigorous research and development. With a focus on delivering high-quality therapeutic solutions, SERF collaborates with healthcare professionals and institutions to conduct comprehensive clinical studies that adhere to the highest ethical and regulatory standards. The organization leverages its expertise in various therapeutic areas to support the development of new treatments, aiming to improve patient outcomes and contribute to the global healthcare landscape.

Locations

Pierre Bénite, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported